Cargando…

Tyrosine capsid-mutant AAV vectors for gene delivery to the canine retina from a subretinal or intravitreal approach

Recombinant adeno-associated viruses are important vectors for retinal gene delivery. Currently utilized vectors have relatively slow onset and for efficient transduction it is necessary to deliver treatment subretinally, with the potential for damage to the retina. Amino-acid substitutions in the v...

Descripción completa

Detalles Bibliográficos
Autores principales: Mowat, FM, Gornik, KR, Dinculescu, A, Boye, SL, Hauswirth, WW, Petersen-Jones, SM, Bartoe, JT
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3880610/
https://www.ncbi.nlm.nih.gov/pubmed/24225638
http://dx.doi.org/10.1038/gt.2013.64
_version_ 1782298097112580096
author Mowat, FM
Gornik, KR
Dinculescu, A
Boye, SL
Hauswirth, WW
Petersen-Jones, SM
Bartoe, JT
author_facet Mowat, FM
Gornik, KR
Dinculescu, A
Boye, SL
Hauswirth, WW
Petersen-Jones, SM
Bartoe, JT
author_sort Mowat, FM
collection PubMed
description Recombinant adeno-associated viruses are important vectors for retinal gene delivery. Currently utilized vectors have relatively slow onset and for efficient transduction it is necessary to deliver treatment subretinally, with the potential for damage to the retina. Amino-acid substitutions in the viral capsid improve efficiency in rodent eyes by evading host responses. As dogs are important large animal models for human retinitis pigmentosa, we evaluated the speed and efficiency of retinal transduction using capsid-mutant vectors injected both subretinally and intravitreally. We evaluated AAV serotypes 2 and 8 with amino-acid substitutions of surface exposed capsid tyrosine residues. The chicken beta-actin promoter was used to drive green fluorescent protein expression. Twelve normal adult beagles were injected, 4 dogs received intravitreal injections, 8 dogs received subretinal injections. Capsid-mutant viruses tested included AAV2(quad Y-F) (intravitreal and subretinal), and self-complementary scAAV8(Y733F) (subretinal only). Contralateral control eyes received injections of scAAV5 (subretinal) or scAAV2 (intravitreal). Subretinally delivered vectors had a faster expression onset than intravitreally delivered vectors. Subretinally delivered scAAV8(Y733F) had a faster onset of expression than scAAV5. All subretinally injected vector types transduced the outer retina with high efficiency, and the inner retina with moderate efficiency. Intravitreally delivered AAV2(quad Y-F) had a marginally higher efficiency of transduction of both outer retinal and inner retinal cells than scAAV2. Because of their rapid expression onset and efficient transduction, subretinally delivered capsid-mutant AAV8 vectors may increase the efficacy of gene therapy treatment for rapid photoreceptor degenerative diseases. With further refinement, capsid-mutant AAV2 vectors show promise for retinal gene delivery from an intravitreal approach.
format Online
Article
Text
id pubmed-3880610
institution National Center for Biotechnology Information
language English
publishDate 2013
record_format MEDLINE/PubMed
spelling pubmed-38806102014-07-01 Tyrosine capsid-mutant AAV vectors for gene delivery to the canine retina from a subretinal or intravitreal approach Mowat, FM Gornik, KR Dinculescu, A Boye, SL Hauswirth, WW Petersen-Jones, SM Bartoe, JT Gene Ther Article Recombinant adeno-associated viruses are important vectors for retinal gene delivery. Currently utilized vectors have relatively slow onset and for efficient transduction it is necessary to deliver treatment subretinally, with the potential for damage to the retina. Amino-acid substitutions in the viral capsid improve efficiency in rodent eyes by evading host responses. As dogs are important large animal models for human retinitis pigmentosa, we evaluated the speed and efficiency of retinal transduction using capsid-mutant vectors injected both subretinally and intravitreally. We evaluated AAV serotypes 2 and 8 with amino-acid substitutions of surface exposed capsid tyrosine residues. The chicken beta-actin promoter was used to drive green fluorescent protein expression. Twelve normal adult beagles were injected, 4 dogs received intravitreal injections, 8 dogs received subretinal injections. Capsid-mutant viruses tested included AAV2(quad Y-F) (intravitreal and subretinal), and self-complementary scAAV8(Y733F) (subretinal only). Contralateral control eyes received injections of scAAV5 (subretinal) or scAAV2 (intravitreal). Subretinally delivered vectors had a faster expression onset than intravitreally delivered vectors. Subretinally delivered scAAV8(Y733F) had a faster onset of expression than scAAV5. All subretinally injected vector types transduced the outer retina with high efficiency, and the inner retina with moderate efficiency. Intravitreally delivered AAV2(quad Y-F) had a marginally higher efficiency of transduction of both outer retinal and inner retinal cells than scAAV2. Because of their rapid expression onset and efficient transduction, subretinally delivered capsid-mutant AAV8 vectors may increase the efficacy of gene therapy treatment for rapid photoreceptor degenerative diseases. With further refinement, capsid-mutant AAV2 vectors show promise for retinal gene delivery from an intravitreal approach. 2013-11-14 2014-01 /pmc/articles/PMC3880610/ /pubmed/24225638 http://dx.doi.org/10.1038/gt.2013.64 Text en Users may view, print, copy, download and text and data- mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use: http://www.nature.com/authors/editorial_policies/license.html#terms
spellingShingle Article
Mowat, FM
Gornik, KR
Dinculescu, A
Boye, SL
Hauswirth, WW
Petersen-Jones, SM
Bartoe, JT
Tyrosine capsid-mutant AAV vectors for gene delivery to the canine retina from a subretinal or intravitreal approach
title Tyrosine capsid-mutant AAV vectors for gene delivery to the canine retina from a subretinal or intravitreal approach
title_full Tyrosine capsid-mutant AAV vectors for gene delivery to the canine retina from a subretinal or intravitreal approach
title_fullStr Tyrosine capsid-mutant AAV vectors for gene delivery to the canine retina from a subretinal or intravitreal approach
title_full_unstemmed Tyrosine capsid-mutant AAV vectors for gene delivery to the canine retina from a subretinal or intravitreal approach
title_short Tyrosine capsid-mutant AAV vectors for gene delivery to the canine retina from a subretinal or intravitreal approach
title_sort tyrosine capsid-mutant aav vectors for gene delivery to the canine retina from a subretinal or intravitreal approach
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3880610/
https://www.ncbi.nlm.nih.gov/pubmed/24225638
http://dx.doi.org/10.1038/gt.2013.64
work_keys_str_mv AT mowatfm tyrosinecapsidmutantaavvectorsforgenedeliverytothecanineretinafromasubretinalorintravitrealapproach
AT gornikkr tyrosinecapsidmutantaavvectorsforgenedeliverytothecanineretinafromasubretinalorintravitrealapproach
AT dinculescua tyrosinecapsidmutantaavvectorsforgenedeliverytothecanineretinafromasubretinalorintravitrealapproach
AT boyesl tyrosinecapsidmutantaavvectorsforgenedeliverytothecanineretinafromasubretinalorintravitrealapproach
AT hauswirthww tyrosinecapsidmutantaavvectorsforgenedeliverytothecanineretinafromasubretinalorintravitrealapproach
AT petersenjonessm tyrosinecapsidmutantaavvectorsforgenedeliverytothecanineretinafromasubretinalorintravitrealapproach
AT bartoejt tyrosinecapsidmutantaavvectorsforgenedeliverytothecanineretinafromasubretinalorintravitrealapproach